By attending the WSF teaching course for industry partners, you will be able to:
Understand strategies to identify targets for therapy in SSc
Weight the natural course of the disease
Have an overview on outcome measures in practice and clinical trials
Discuss the future of clinical trial design
The course targets industry colleagues who are planning to work or are already working in the field of SSc.
- 2019 Bruni different stages scenarios of skin fibrosis
- Skin assessment and certification Denton IW 2019 final
- QA Panel discussion with senior faculty
- Prof Matucci Clinical overview defining the unmet need in scleroderma evidence based therapy
- Prof Khanna Regulatory Approval Scleroderma WSF
- Prof Distler Pathophysiology of systemic sclerosis forward and reverse translation
- Dr Lepri The Lung Disease inSSc
- Campochiaro Raynaudsand DUs cd
- Prof DelGaldo WSFEUSTAR insdustry workshop
- Denton outcomes in lcSSc and potential
- DentonPitfalls-and-promise-Florence-2019
- Skin assessment and certification Denton
Panel discussion- Senior faculty of the workshop @Worldsclerofnd @EUSTAR_org 3rd #IndusrtyWorkshop2019 pic.twitter.com/Lm4axrGegf
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Prof. Khanna’s @sclerodermaUM talk on: “ What is likely to be needed for regulatory approval of a new drug in SSc in EU and USA” at the 3rd @Worldsclerofnd @EUSTAR_org #IndustryWorkshop2019 pic.twitter.com/5OjdNoKJHA
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Dr. Lepri’s case based discussion on: “ the lung disease” at the 3rd @Worldsclerofnd @EUSTAR_org #IndusrtyWorkshop2019 pic.twitter.com/Gv4oSlA2fh
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Dr. Campochiaro’s case based discussion on: “ Raynaud’s and digital ulcers” at the 3rd @Worldsclerofnd @EUSTAR_org #IndustryWorkshop2019 pic.twitter.com/z9CAc2YT7F
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Dr. Bruni’s case based discussion on: “ the skin in diffuse disease” at the 3rd @Worldsclerofnd @EUSTAR_org #IndustryWorkshop2019 pic.twitter.com/Zbew0BXtSq
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Prof. Del Galdo’s talk on: “ Composite endpoint and biomarkers” at the 3rd @Worldsclerofnd @EUSTAR_org #IndusrtyWorkshop2019 pic.twitter.com/AkvM75m4i9
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Prof. Maher’s talk on: “ Lung function, imaging and PROs” at the @Worldsclerofnd @EUSTAR_org #IndustryWorkshop2019 pic.twitter.com/fToMDkWW15
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Prof. Matucci Cerinci’s talk on:” Clinical overview-defining the umnet need in SSc- evidence based therapy “ at the 3rd @Worldsclerofnd @eurordis #IndustryWorkshop2019 pic.twitter.com/hYyDC5UtoU
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Prof. Denton’s presentation on: “ Pitfalls and promise from recent scleroderma trial” at the 3rd @Worldsclerofnd @EUSTAR_org #IndusrtyWorkshop2019 pic.twitter.com/J4XeXMhIl1
— World Scleroderma Foundation (@Worldsclerofnd) 6 settembre 2019
Preclinical development for SSc indications
Industry-academic cooperation in drug development and beyond
Modified Rodnan skin score
Denton Trial design 2018
The SSc community – overview of registries and educational opportunities in SSc
